1. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial. Issue 9 (September 2020) Authors: Patil, Vijay; Noronha, Vanita; Dhumal, Sachin Babanrao; Joshi, Amit; Menon, Nandini; Bhattacharjee, Atanu; Kulkarni, Suyash; Ankathi, Suman Kumar; Mahajan, Abhishek; Sable, Nilesh; Nawale, Kavita; Bhelekar, Arti; Mukadam, Sadaf; Chandrasekharan, Arun; Das, Sudeep; Vallathol, Dilip; D'Souza, Holli... Journal: Lancet Issue: Volume 8:Issue 9(2020) Page Start: e1213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗